Joshua S Jue1, Sydney A Spector2, Seth A Spector3. 1. Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida. 2. Surgical Service, Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, Florida. 3. Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida; Surgical Service, Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, Florida. Electronic address: JSJ16@med.miami.edu.
Abstract
BACKGROUND: Surgical and nonsurgical specialists are highly centralized, making access to high-quality care difficult for many Americans. We explored the feasibility, benefits, preliminary outcomes, and patient satisfaction with a new type of health visit, in which a surgical oncologist used video telecommunication to manage and treat complex cancer diseases, including patients with severe comorbidities. MATERIALS AND METHODS: Patients visited local VA medical centers throughout Florida to engage in video telecommunication visits with a centralized surgical oncologist in Miami, who directed their oncology treatment. The average length of stay and rate of unplanned readmission were calculated within each organ. The total mileage saved was calculated by subtracting the distance between the patient's home address and the local VA from the distance between the patient's home address and the Miami VA. Travel costs were determined by the VA's reimbursement of $0.415/mile for health-related travel and reimbursement of $150.00 for an overnight hotel stay. A Likert scale with both positively and negatively keyed questions was used to assess patient satisfaction. RESULTS: In 24 mo, seven unplanned readmissions occurred among 195 operations. Patients experienced an 80.7% reduction in travel distance and saved a total of 213,007.58 miles by visiting their local VA instead of the Miami VA. Survey results indicate that 86% of patients believed that the telemedicine program made medical care more accessible. CONCLUSIONS: The Specialist-Directed Telemedicine Model can save patients substantial time and money by not traveling to centralized areas, while delivering greater continuity of care and patient satisfaction.
BACKGROUND: Surgical and nonsurgical specialists are highly centralized, making access to high-quality care difficult for many Americans. We explored the feasibility, benefits, preliminary outcomes, and patient satisfaction with a new type of health visit, in which a surgical oncologist used video telecommunication to manage and treat complex cancer diseases, including patients with severe comorbidities. MATERIALS AND METHODS:Patients visited local VA medical centers throughout Florida to engage in video telecommunication visits with a centralized surgical oncologist in Miami, who directed their oncology treatment. The average length of stay and rate of unplanned readmission were calculated within each organ. The total mileage saved was calculated by subtracting the distance between the patient's home address and the local VA from the distance between the patient's home address and the Miami VA. Travel costs were determined by the VA's reimbursement of $0.415/mile for health-related travel and reimbursement of $150.00 for an overnight hotel stay. A Likert scale with both positively and negatively keyed questions was used to assess patient satisfaction. RESULTS: In 24 mo, seven unplanned readmissions occurred among 195 operations. Patients experienced an 80.7% reduction in travel distance and saved a total of 213,007.58 miles by visiting their local VA instead of the Miami VA. Survey results indicate that 86% of patients believed that the telemedicine program made medical care more accessible. CONCLUSIONS: The Specialist-Directed Telemedicine Model can save patients substantial time and money by not traveling to centralized areas, while delivering greater continuity of care and patient satisfaction.
Authors: Lisa P Spees; Wendy R Brewster; Mahesh A Varia; Morris Weinberger; Christopher Baggett; Xi Zhou; Victoria M Petermann; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Allison Gossen; Beth Mehring; Brian S Gunnell; Karen S Rheuban; David C Cattell-Gordon; Kyle B Enfield; Costi D Sifri Journal: Ann Am Thorac Soc Date: 2020-06
Authors: Tuya Pal; Pamela C Hull; Tatsuki Koyama; Phillip Lammers; Denise Martinez; Jacob McArthy; Emma Schremp; Ann Tezak; Anne Washburn; Jennifer G Whisenant; Debra L Friedman Journal: BMC Cancer Date: 2021-11-23 Impact factor: 4.430
Authors: Jordan M Alpert; Greenberry Taylor; Chelsea N Hampton; Samantha Paige; Merry Jennifer Markham; Carma L Bylund Journal: JMIR Cancer Date: 2022-02-24